Data Sheet 1_Sporoderm-removed ganoderma lucidum spore powder (S-GLSP) alleviates neuroinflammation injury by regulating microglial polarization through inhibition of NLRP3 inflammasome activation.pdf

Introduction<p>Sporoderm-Removed Ganoderma lucidum Spore Powder (S-GLSP), derived from the spores of the medically valued fungus Ganoderma lucidum, exhibits diverse pharmacological activities and shows considerable potential in the treatment of Alzheimer’s disease (AD). However, its underlying...

Täydet tiedot

Bibliografiset tiedot

Päätekijä:	Wenli Li (337819) (author)
Muut tekijät:	Wei Huang (36889) (author), Peng Zhou (116747) (author), Yongchuan Yao (22679309) (author), Biao Cai (4288222) (author), Shu Ye (44563) (author)
Julkaistu:	2025
Aiheet:	Pharmacology sporoderm-removed ganoderma lucidum spore powder Alzheimer’s disease microglial polarization neuroinflammation NLRP3 inflammasome
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!